RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 118 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,452,000 | +222.0% | 485,638 | +185.4% | 0.00% | – |
| Q4 2021 | $451,000 | -45.1% | 170,184 | -24.7% | 0.00% | – |
| Q3 2021 | $821,000 | -20.9% | 226,099 | -5.5% | 0.00% | -100.0% |
| Q2 2021 | $1,038,000 | +33.4% | 239,275 | +5.2% | 0.00% | – |
| Q1 2021 | $778,000 | +100.5% | 227,399 | +105.2% | 0.00% | – |
| Q4 2020 | $388,000 | +52.8% | 110,819 | +4.7% | 0.00% | – |
| Q3 2020 | $254,000 | +19.2% | 105,862 | -8.9% | 0.00% | – |
| Q2 2020 | $213,000 | +55.5% | 116,172 | +32.2% | 0.00% | – |
| Q1 2020 | $137,000 | -70.2% | 87,874 | -59.0% | 0.00% | – |
| Q4 2019 | $459,000 | +40.8% | 214,329 | +22.8% | 0.00% | – |
| Q3 2019 | $326,000 | -24.4% | 174,587 | +5.6% | 0.00% | – |
| Q2 2019 | $431,000 | +902.3% | 165,251 | +887.5% | 0.00% | – |
| Q1 2019 | $43,000 | -20.4% | 16,735 | -29.2% | 0.00% | – |
| Q4 2018 | $54,000 | -73.7% | 23,633 | -63.0% | 0.00% | – |
| Q3 2018 | $205,000 | +3.0% | 63,948 | -9.2% | 0.00% | – |
| Q2 2018 | $199,000 | +87.7% | 70,452 | +135.9% | 0.00% | – |
| Q1 2018 | $106,000 | +21.8% | 29,869 | +33.1% | 0.00% | – |
| Q4 2017 | $87,000 | +38.1% | 22,440 | -10.1% | 0.00% | – |
| Q3 2017 | $63,000 | -22.2% | 24,953 | -16.1% | 0.00% | – |
| Q2 2017 | $81,000 | -20.6% | 29,728 | -3.5% | 0.00% | – |
| Q1 2017 | $102,000 | +54.5% | 30,815 | +11.3% | 0.00% | – |
| Q4 2016 | $66,000 | -80.4% | 27,697 | -69.7% | 0.00% | -100.0% |
| Q3 2016 | $336,000 | +16.7% | 91,459 | -29.1% | 0.00% | – |
| Q2 2016 | $288,000 | +9.9% | 129,067 | +2.6% | 0.00% | – |
| Q1 2016 | $262,000 | -33.2% | 125,768 | -2.9% | 0.00% | -100.0% |
| Q4 2015 | $392,000 | +27.3% | 129,498 | +3.9% | 0.00% | 0.0% |
| Q3 2015 | $308,000 | +14.5% | 124,607 | +48.8% | 0.00% | 0.0% |
| Q2 2015 | $269,000 | +2.3% | 83,733 | +13.7% | 0.00% | 0.0% |
| Q1 2015 | $263,000 | +64.4% | 73,636 | +4.4% | 0.00% | – |
| Q4 2014 | $160,000 | +83.9% | 70,559 | +57.8% | 0.00% | – |
| Q3 2014 | $87,000 | -66.7% | 44,723 | -37.7% | 0.00% | -100.0% |
| Q2 2014 | $261,000 | -22.1% | 71,767 | -16.9% | 0.00% | 0.0% |
| Q1 2014 | $335,000 | +51.6% | 86,345 | +11.4% | 0.00% | 0.0% |
| Q4 2013 | $221,000 | +55.6% | 77,479 | +95.3% | 0.00% | – |
| Q3 2013 | $142,000 | – | 39,675 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
| Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
| ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
| NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
| Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
| XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |